Polianta LTD Biogen Inc. Transaction History

Polianta LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 07, 2020	SELL	$264.77 - $305.71 $1.01 Million - $1.16 Million	-3,800 Closed	0 $0
Q2 2020 Jul 09, 2020	BUY	$258.66 - $342.55 $982,908 - $1.3 Million	3,800 New	3,800 $1.02 Million
Q1 2019 Apr 04, 2019	SELL	$216.71 - $338.96 $764,986 - $1.2 Million	-3,530 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$278.5 - $352.75 $983,105 - $1.25 Million	3,530 New	3,530 $1.06 Million
Q3 2018 Oct 15, 2018	SELL	$293.51 - $383.83 $1.17 Million - $1.54 Million	-4,000 Closed	0 $0
Q2 2018 Jul 10, 2018	BUY	$257.52 - $306.91 $1.03 Million - $1.23 Million	4,000 New	4,000 $1.16 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

Stay updated on Polianta LTD with notifications on news.